| Literature DB >> 20015227 |
Valeria Leonhardt1, José H Leal-Cardoso, Saad Lahlou, Aline A C Albuquerque, Romulo S Porto, Natalia R Celedônio, Ariclecio C Oliveira, Renalison F Pereira, Leidiane P Silva, Taylena M N Garcia-Teófilo, Anna P F S Silva, Pedro J C Magalhães, Gloria P Duarte, Andrelina N Coelho-de-Souza.
Abstract
This study investigates the effects of essential oil of Pterodon polygalaeflorus (EOPP) and β-caryophyllene (β-CAR). EOPP and β-CAR relaxed the basal tone of ileum smooth muscle in a concentration-dependent manner (IC(50) s = 394.35 ± 62.12 and 68.65 ± 9.51 μg/mL respectively), an effect that was unaltered by hexamethonium, L-nitroarginine methyl ester or indomethacin. Both EOPP and β-CAR evoked a concentration-dependent relaxation of ileum pre-contracted with KCl with an IC(50) value of 107.78 ± 10.47 and 17.35 ± 0.75 μg/mL, respectively. EOPP and β-CAR inhibited the contractions induced by acetylcholine (ACh) and by KCl. In ileal preparations, the CaCl(2) -induced contractions were reduced by EOPP (300 μg/mL) and β-CAR (100 μg/mL). Furthermore, CaCl(2) -induced contractions were also reduced by EOPP (300 μg/mL) and β-CAR (100 μg/mL) in ileal preparations pretreated with ACh under Ca(2+) -free condition and in the presence of verapamil. EOPP (100 and 300 μg/mL) and β-CAR (30 and 100 μg/mL) reduced the ACh-induced contractions of isolated rat ileum under Ca(2+) -free conditions. In the presence of high KCl and Ca(2+) -free conditions, EOPP (300 μg/mL) and β-CAR (100 μg/mL) reduced the contractions induced by barium. A similar effect was also observed with verapamil. It is concluded that (i) β-CAR is an important constituent involved in the myorelaxant and antispasmodic effects induced by EOPP; (ii) the inhibitory effect on intestinal contractility is myogenic and seems mainly mediated through an intracellular mechanism. However, the ability of EOPP and β-CAR to decrease Ca(2+) influx through cytoplasmic membrane could not be discounted.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20015227 DOI: 10.1111/j.1472-8206.2009.00800.x
Source DB: PubMed Journal: Fundam Clin Pharmacol ISSN: 0767-3981 Impact factor: 2.748